Completed Access to Information Requests

About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Current Search

Report Type

Organization

Disposition

Year

Month

Found 202 record(s)

Req # A-2022-000096

Adverse Drug Reactions (ADRs) for ALEMTUZUMAB, FUROSEMIDE DANAZOL. Report numbers: E2B_04983075, E2B_05082215, E2B_05056270.

Organization: Health Canada

55 page(s)
July 2022

Req # A-2022-000121

Adverse Drug Reactions (ADRs) for BISACODYL, DOCUSATE SODIUM. Report numbers: 000980262, E2B_04987682.

Organization: Health Canada

24 page(s)
July 2022

Req # A-2022-000148

Adverse Drug Reaction (ADR) for ZOSTAVAX II. Report number: E2B_02575430.

Organization: Health Canada

7 page(s)
July 2022

Req # A-2022-000273

Adverse Drug Reaction (ADR). Report number: 000985525.

Organization: Health Canada

2 page(s)
July 2022

Req # A-2016-001556

All briefing materials provided to the Minister of Health regarding Apotex Inc., AA Pharma, and/or the drug Mefloquine also known under the brand name Lariam from November 1, 2015 and January 13, 2017.

Organization: Health Canada

56 page(s)
December 2021

Req # A-2020-000769

The name of the manufacturer of the LAP-BAND Adjustable Gastric Banding (LAGB) System (License No. 12197) medical device as of the device's first issuance date September 20, 1999.

Organization: Health Canada

2 page(s)
December 2021

Req # A-2020-000770

A copy of the Medical Device License of the LAP-BAND Adjustable Gastric Banding (LAGB) System (License No. 12197) medical device as of the device's first issuance date September 20, 1999.

Organization: Health Canada

2 page(s)
December 2021

Req # A-2021-000924

Copies of the "Section 3: Shipment Details" of every "Application for Permit to Import Cannabis for Medical or Scientific Purposes" approved in 2020 and 2021.

Organization: Health Canada

222 page(s)
December 2021

Req # A-2021-001190

A report from Health Canada's Medical Device Directorate which includes a list of active/conditional that have Class II Medical licenses which are classified as Software as a Medical Device (SaMD) from Canadian Manufacturers excluding, where…

Organization: Health Canada

21 page(s)
December 2021

Req # A-2021-001249

Most recent version of the integrated business plan, performance measurement framework/result report and recruitment and staffing strategies from FY2021/2022 at the branch level only for the following branches: Pest Management Regulatory Agency,…

Organization: Health Canada

167 page(s)
December 2021
Date modified: